A Multistep Tumor Growth Model of High-Grade Serous Ovarian Carcinoma Identifies Hypoxia-Associated Signatures

2.

Anttila

MA

,

Tammi

RH

,

Tammi

MI

,

Syrjänen

KJ

,

Saarikoski

SV

,

Kosma

VM

.

High levels of stromal hyaluronan predict poor disease outcome in epithelial ovarian cancer

.

Cancer Res

.

2000

;

60

(

1

):

150

–

5

.

3.

Balamurugan

K

.

HIF-1 at the crossroads of hypoxia, inflammation, and cancer: hypoxia, inflammation, and cancer

.

Int J Cancer

.

2016

;

138

(

5

):

1058

–

66

.

4.

Balzer

EM

,

Konstantopoulos

K

.

Intercellular adhesion: mechanisms for growth and metastasis of epithelial cancers

.

Wiley Interdiscip Rev Syst Biol Med

.

2012

;

4

(

2

):

171

–

81

.

5.

Bapat

SA

,

Krishnan

A

,

Ghanate

AD

,

Kusumbe

AP

,

Kalra

RS

.

Gene expression: protein interaction systems network modeling identifies transformation-associated molecules and pathways in ovarian cancer

.

Cancer Res

.

2010

;

70

(

12

):

4809

–

19

.

6.

Bapat

SA

,

Mali

AM

,

Koppikar

CB

,

Kurrey

NK

.

Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer

.

Cancer Res

.

2005

;

65

(

8

):

3025

–

9

.

7.

Benita

Y

,

Kikuchi

H

,

Smith

AD

,

Zhang

MQ

,

Chung

DC

,

Xavier

RJ

.

An integrative genomics approach identifies Hypoxia Inducible Factor-1 (HIF-1)-target genes that form the core response to hypoxia

.

Nucleic Acids Res

.

2009

;

37

(

14

):

4587

–

602

.

8.

Berger

AC

,

Korkut

A

,

Kanchi

RS

,

Hegde

AM

,

Lenoir

W

,

Liu

W

, et al.

A comprehensive pan-cancer molecular study of gynecologic and breast cancers

.

Cancer Cell

.

2018

;

33

(

4

):

690

–

705.e9

.

9.

Bourguignon

LYW

,

Shiina

M

,

Li

J-J

.

Hyaluronan-CD44 interaction promotes oncogenic signaling, microRNA functions, chemoresistance, and radiation resistance in cancer stem cells leading to tumor progression

.

Adv Cancer Res

.

2014

;

123

:

255

–

75

.

10.

Bryant

CS

,

Munkarah

AR

,

Kumar

S

,

Batchu

RB

,

Shah

JP

,

Berman

J

, et al.

Reduction of hypoxia-induced angiogenesis in ovarian cancer cells by inhibition of HIF-1 alpha gene expression

.

Arch Gynecol Obstet

.

2010

;

282

(

6

):

677

–

83

.

11.

Byers

LA

,

Diao

L

,

Wang

J

,

Saintigny

P

,

Girard

L

,

Peyton

M

, et al.

An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistance

.

Clin Cancer Res

.

2013

;

19

(

1

):

279

–

90

.

12.

Chanmee

T

,

Ontong

P

,

Izumikawa

T

,

Higashide

M

,

Mochizuki

N

,

Chokchaitaweesuk

C

, et al.

Hyaluronan production regulates metabolic and cancer stem-like properties of breast cancer cells via hexosamine biosynthetic pathway-coupled HIF-1 signaling

.

J Biol Chem

.

2016

;

291

(

46

):

24105

–

20

.

13.

Chen

B

,

Khodadoust

MS

,

Liu

CL

,

Newman

AM

,

Alizadeh

AA

.

Profiling tumor infiltrating immune cells with CIBERSORT

.

Methods Mol Biol

.

2018

;

1711

:

243

–

59

.

14.

Cormio

G

,

Rossi

C

,

Cazzolla

A

,

Resta

L

,

Loverro

G

,

Greco

P

, et al.

Distant metastases in ovarian carcinoma

.

Int J Gynecol Cancer

.

2003

;

13

(

2

):

125

–

9

.

15.

Cybulska

P

,

Stewart

JM

,

Sayad

A

,

Virtanen

C

,

Shaw

PA

,

Clarke

B

, et al.

A genomically characterized collection of high-grade serous ovarian cancer xenografts for preclinical testing

.

Am J Pathol

.

2018

;

188

(

5

):

1120

–

31

.

16.

D’Ignazio

L

,

Bandarra

D

,

Rocha

S

.

NF-κB and HIF crosstalk in immune responses

.

FEBS J

.

2016

;

283

(

3

):

413

–

24

.

17.

Davidson

B

,

Trope

CG

,

Reich

R

.

The role of the tumor stroma in ovarian cancer

.

Front Oncol

.

2014

;

4

:

1

–

11

.

18.

De Nola

R

,

Menga

A

,

Castegna

A

,

Loizzi

V

,

Ranieri

G

,

Cicinelli

E

, et al.

The crowded crosstalk between cancer cells and stromal microenvironment in gynecological malignancies: biological pathways and therapeutic implication

.

Int J Mol Sci

.

2019

;

20

(

10

):

E2401

–

29

.

19.

Deng

K

,

Yang

C

,

Tan

Q

,

Song

W

,

Lu

M

,

Zhao

W

, et al.

Sites of distant metastases and overall survival in ovarian cancer: a study of 1481 patients

.

Gynecol Oncol

.

2018

;

150

(

3

):

460

–

5

.

20.

Domcke

S

,

Sinha

R

,

Levine

DA

,

Sander

C

,

Schultz

N

.

Evaluating cell lines as tumour models by comparison of genomic profiles

.

Nat Commun

.

2013

;

4

:

2126

–

10

.

21.

Du

R

,

Sun

W

,

Xia

L

,

Zhao

A

,

Yu

Y

,

Zhao

L

, et al.

Hypoxia-induced down-regulation of microRNA-34a promotes EMT by targeting the Notch signaling pathway in tubular epithelial cells

.

PLoS One

.

2012

;

7

(

2

):

e30771

.

22.

Eales

KL

,

Hollinshead

KER

,

Tennant

DA

.

Hypoxia and metabolic adaptation of cancer cells

.

Oncogenesis

.

2016

;

5

(

1

):

e190

.

23.

Faustino-Rocha

A

,

Oliveira

PA

,

Pinho-Oliveira

J

,

Teixeira-Guedes

C

,

Soares-Maia

R

,

da Costa

RG

, et al.

Estimation of rat mammary tumor volume using caliper and ultrasonography measurements

.

Lab Anim

.

2013

;

42

(

6

):

217

–

24

.

24.

Gaikwad

SM

,

Gunjal

L

,

Junutula

AR

,

Astanehe

A

,

Gambhir

SS

,

Ray

P

.

Non-invasive imaging of phosphoinositide-3-kinase-catalytic-subunit-alpha (PIK3CA) promoter modulation in small animal models

.

PLoS One

.

2013

;

8

(

2

):

e55971

.

25.

Gardi

NL

,

Deshpande

TU

,

Kamble

SC

,

Budhe

SR

,

Bapat

SA

.

Discrete molecular classes of ovarian cancer suggestive of unique mechanisms of transformation and metastases

.

Clin Cancer Res

.

2014

;

20

(

1

):

87

–

99

.

26.

George

JT

,

Jolly

MK

,

Xu

S

,

Somarelli

JA

,

Levine

H

.

Survival outcomes in cancer patients predicted by a partial EMT gene expression scoring metric

.

Cancer Res

.

2017

;

77

(

22

):

6415

–

28

.

27.

Gilkes

DM

,

Semenza

GL

,

Wirtz

D

.

Hypoxia and the extracellular matrix: drivers of tumour metastasis

.

Nat Rev Cancer

.

2014

;

14

(

6

):

430

–

9

.

28.

Gomez-Roman

N

,

Sahasrabudhe

NM

,

McGregor

F

,

Chalmers

AJ

,

Cassidy

J

,

Plumb

J

.

Hypoxia-inducible factor 1 alpha is required for the tumourigenic and aggressive phenotype associated with Rab25 expression in ovarian cancer

.

Oncotarget

.

2016

;

7

(

16

):

22650

–

64

.

29.

Han

J

,

Xi

Q

,

Meng

Q

,

Liu

J

,

Zhang

Y

,

Han

Y

, et al.

Interleukin-6 promotes tumor progression in colitis-associated colorectal cancer through HIF-1α regulation

.

Oncol Lett

.

2016

;

12

(

6

):

4665

–

70

.

30.

Hanahan

D

,

Weinberg

RA

.

Hallmarks of cancer: the next generation

.

Cell

.

2011

;

144

(

5

):

646

–

74

.

31.

Hanahan

D

,

Weinberg

RA

.

The hallmarks of cancer

.

Cell

.

2000

;

100

(

1

):

57

–

70

.

32.

Harris

AL

.

Hypoxia: a key regulatory factor in tumour growth

.

Nat Rev Cancer

.

2002

;

2

(

1

):

38

–

47

.

33.

Harris

FR

,

Zhang

P

,

Yang

L

,

Hou

X

,

Leventakos

K

,

Weroha

SJ

, et al.

Targeting HER2 in patient-derived xenograft ovarian cancer models sensitizes tumors to chemotherapy

.

Mol Oncol

.

2019

;

13

(

2

):

132

–

52

.

34.

Hemmerlein

B

,

Kugler

A

,

Özisik

R

,

Ringert

RH

,

Radzun

HJ

,

Thelen

P

.

Vascular endothelial growth factor expression, angiogenesis, and necrosis in renal cell carcinomas

.

Virchows Arch

.

2001

;

439

(

5

):

645

–

52

.

35.

Hjerpe

E

,

Egyhazi Brage

S

,

Carlson

J

,

Frostvik Stolt

M

,

Schedvins

K

,

Johansson

H

, et al.

Metabolic markers GAPDH, PKM2, ATP5B and BEC-index in advanced serous ovarian cancer

.

BMC Clin Pathol

.

2013

;

13

(

1

):

30

.

36.

Horvath

LE

,

Werner

T

,

Boucher

K

,

Jones

K

.

The relationship between tumor size and stage in early versus advanced ovarian cancer

.

Med Hypotheses

.

2013

;

80

(

5

):

684

–

7

.

37.

Huang

B

,

Lu

M

,

Jia

D

,

Ben-Jacob

E

,

Levine

H

,

Onuchic

JN

.

Interrogating the topological robustness of gene regulatory circuits by randomization

.

PLoS Comput Biol

.

2017

;

13

(

3

):

e1005456

.

38.

Hubbi

ME

,

Semenza

GL

.

Regulation of cell proliferation by hypoxia-inducible factors

.

Am J Physiol Cell Physiol

.

2015

;

309

(

12

):

C775

–

82

.

39.

Imai

T

,

Horiuchi

A

,

Wang

C

,

Oka

K

,

Ohira

S

,

Nikaido

T

, et al.

Hypoxia attenuates the expression of E-cadherin via up-regulation of SNAIL in ovarian carcinoma cells

.

Am J Pathol

.

2003

;

163

(

4

):

1437

–

47

.

40.

Jolly

MK

,

Boareto

M

,

Huang

B

,

Jia

D

,

Lu

M

,

Onuchic

JN

, et al.

Implications of the hybrid epithelial/mesenchymal phenotype in metastasis

.

Front Oncol

.

2015

;

5

:

1

–

19

.

41.

Jolly

MK

,

Preca

B-T

,

Tripathi

SC

,

Jia

D

,

George

JT

,

Hanash

SM

, et al.

Interconnected feedback loops among ESRP1, HAS2, and CD44 regulate epithelial-mesenchymal plasticity in cancer

.

APL Bioeng

.

2018

;

2

(

3

):

031908

.

42.

Kalra

RS

,

Bapat

SA

.

Expression proteomics predicts loss of RXR-γ during progression of epithelial ovarian cancer

.

PLoS One

.

2013

;

8

(

8

):

e70398

.

43.

Kamble

SC

,

Sen

A

,

Dhake

RD

,

Joshi

AN

,

Midha

D

,

Bapat

SA

.

Clinical stratification of high-grade ovarian serous carcinoma using a panel of six biomarkers

.

J Clin Med

.

2019

;

8

(

3

):

330

.

44.

Krock

BL

,

Skuli

N

,

Simon

MC

.

Hypoxia-induced angiogenesis: good and evil

.

Genes Cancer

.

2011

;

2

(

12

):

1117

–

33

.

45.

Kusumbe

AP

,

Bapat

SA

.

Cancer stem cells and aneuploid populations within developing tumors are the major determinants of tumor dormancy

.

Cancer Res

.

2009

;

69

(

24

):

9245

–

53

.

46.

Kusumbe

AP

,

Mali

AM

,

Bapat

SA

.

CD133-expressing stem cells associated with ovarian metastases establish an endothelial hierarchy and contribute to tumor vasculature

.

Stem Cells

.

2009

;

27

(

3

):

498

–

508

.

47.

Lee

SY

,

Ju

MK

,

Jeon

HM

,

Jeong

EK

,

Lee

YJ

,

Kim

CH

, et al.

Regulation of tumor progression by programmed necrosis

.

Oxid Med Cell Longev

.

2018

;

2018

:

3537471

.

48.

Lengyel

E

.

Ovarian cancer development and metastasis

.

Am J Pathol

.

2010

;

177

(

3

):

1053

–

64

.

49.

Liu

W

,

Ye

H

,

Liu

YF

,

Xu

CQ

,

Zhong

YX

,

Tian

T

, et al.

Transcriptome-derived stromal and immune scores infer clinical outcomes of patients with cancer

.

Oncol Lett

.

2018

;

15

(

4

):

4351

–

7

.

50.

Lu

M

,

Jolly

MK

,

Levine

H

,

Onuchic

JN

,

Ben-Jacob

E

.

MicroRNA-based regulation of epithelial-hybrid-mesenchymal fate determination

.

Proc Natl Acad Sci U S A

.

2013

;

110

(

45

):

18144

–

9

.

51.

Mukoyama

N

,

Suzuki

H

,

Hanai

N

,

Sone

M

,

Hasegawa

Y

.

Pathological tumor volume predicts survival outcomes in oral squamous cell carcinoma

.

Oncol Lett

.

2018

;

16

(

2

):

2471

–

7

.

52.

Muz

B

,

de la Puente

P

,

Azab

F

,

Azab

AK

.

The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy

.

Hypoxia

.

2015

;

3

–

92

.

53.

Naik

RR

,

Gardi

NL

,

Bapat

SA

.

Elucidation of molecular and functional heterogeneity through differential expression network analyses of discrete tumor subsets

.

Sci Rep

.

2016a

;

6

:

25261

.

54.

Naik

RR

,

Luo

T

,

Kohandel

M

,

Bapat

SA

.

Tumor deconstruction as a tool for advanced drug screening and repositioning

.

Pharmacol Res

.

2016b

;

111

:

815

–

9

.

55.

Naik

RR

,

Singh

AK

,

Mali

AM

,

Khirade

MF

,

Bapat

SA

.

A tumor deconstruction platform identifies definitive end points in the evaluation of drug responses

.

Oncogene

.

2016c

;

35

(

6

):

727

–

37

.

56.

Nakazawa

MS

,

Keith

B

,

Simon

MC

.

Oxygen availability and metabolic adaptations

.

Nat Rev Cancer

.

2016

;

16

(

10

):

663

–

73

.

57.

Newman

AM

,

Liu

CL

,

Green

MR

,

Gentles

AJ

,

Feng

W

,

Xu

Y

, et al.

Robust enumeration of cell subsets from tissue expression profiles

.

Nat Methods

.

2015

;

12

(

5

):

453

–

7

.

58.

Petrova

V

,

Annicchiarico-Petruzzelli

M

,

Melino

G

,

Amelio

I

.

The hypoxic tumour microenvironment

.

Oncogenesis

.

2018 Jan 24

;

7

(

1

):

10

.

59.

Pfister

R

,

Schwarz

KA

,

Janczyk

M

,

Dale

R

,

Freeman

JB

.

Good things peak in pairs: a note on the bimodality coefficient

.

Front Psychol

.

2013

;

4

:

700

.

60.

Preca

BT

,

Bajdak

K

,

Mock

K

,

Lehmann

W

,

Sundararajan

V

,

Bronsert

P

, et al.

A novel ZEB1/HAS2 positive feedback loop promotes EMT in breast cancer

.

Oncotarget

.

2017

;

8

(

7

):

11530

–

43

.

61.

Quail

DF

,

Joyce

JA

.

Microenvironmental regulation of tumor progression and metastasis

.

Nat Med

.

2013

;

19

(

11

):

1423

–

37

.

62.

Rose

PG

,

Piver

MS

,

Tsukada

Y

,

Lau

TS

.

Metastatic patterns in histologic variants of ovarian cancer. An autopsy study

.

Cancer

.

1989

;

64

(

7

):

1508

–

13

.

63.

Schaefer

E

,

Wu

W

,

Mark

C

,

Yang

A

,

DiGiacomo

E

,

Carlton-Smith

C

, et al.

Intermittent hypoxia is a proinflammatory stimulus resulting in IL-6 expression and M1 macrophage polarization

.

Hepatol Commun

.

2017

;

1

(

4

):

326

–

37

.

64.

Seeber

LMS

,

Horrée

N

,

van der Groep

P

,

van der Wall

E

,

Verheijen

RHM

,

van Diest

PJ

.

Necrosis related HIF-1α expression predicts prognosis in patients with endometrioid endometrial carcinoma

.

BMC Cancer

.

2010

;

10

:

307

–

11

.

65.

Shaw

TJ

,

Senterman

MK

,

Dawson

K

,

Crane

CA

,

Vanderhyden

BC

.

Characterization of intraperitoneal, orthotopic, and metastatic xenograft models of human ovarian cancer

.

Mol Ther

.

2004

;

10

(

6

):

1032

–

42

.

66.

Singh

AK

,

Chandra

N

,

Bapat

SA

.

Evaluation of epigenetic drug targeting of heterogenous tumor cell fractions using potential biomarkers of response in ovarian cancer

.

Clin Cancer Res

.

2015

;

21

(

22

):

5151

–

63

.

67.

Singh

M

,

Mukundan

S

,

Jaramillo

M

,

Oesterreich

S

,

Sant

S

.

Three-dimensional breast cancer models mimic hallmarks of size-induced tumor progression

.

Cancer Res

.

2016

;

76

(

13

):

3732

–

43

.

68.

Sowter

HM

,

Ratcliffe

PJ

,

Watson

P

,

Greenberg

AH

,

Harris

AL

.

HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors

.

Cancer Res

.

2001

;

61

(

18

):

6669

–

73

.

69.

Tan

TZ

,

Miow

QH

,

Miki

Y

,

Noda

T

,

Mori

S

,

Huang

RYJ

, et al.

Epithelial-mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients

.

EMBO Mol Med

.

2014

;

6

(

10

):

1279

–

93

.

70.

Tomayko

MM

,

Reynolds

CP

.

Determination of subcutaneous tumor size in athymic (nude) mice

.

Cancer Chemother Pharmacol

.

1989

;

24

(

3

):

148

–

54

.

71.

Toole

BP

,

Zoltan-Jones

A

,

Misra

S

,

Ghatak

S

.

Hyaluronan: a critical component of epithelial-mesenchymal and epithelial-carcinoma transitions

.

Cells Tissues Organs

.

2005

;

179

(

1–2

):

66

–

72

.

72.

Tudrej

P

,

Kujawa

KA

,

Cortez

AJ

,

Lisowska

KM

.

Characteristics of in vivo model systems for ovarian cancer studies

.

Diagnostics

.

2019

;

9

(

3

):

120

.

73.

Varankar

SS

,

More

M

,

Abraham

A

,

Pansare

K

,

Kumar

B

,

Narayanan

NJ

, et al.

Functional balance between Tcf21-Slug defines cellular plasticity and migratory modalities in high grade serous ovarian cancer cell lines

.

Carcinogenesis

.

2020

;

41

(

4

):

515

–

26

.

74.

Wang

P

,

Wan

WW

,

Xiong

SL

,

Feng

H

,

Wu

N

.

Cancer stem-like cells can be induced through dedifferentiation under hypoxic conditions in glioma, hepatoma and lung cancer

.

Cell Death Discov

.

2017 Jan 23

;

3

:

16105

.

75.

Wani

AA

,

Sharma

N

,

Shouche

YS

,

Bapat

SA

.

Nuclear-mitochondrial genomic profiling reveals a pattern of evolution in epithelial ovarian tumor stem cells

.

Oncogene

.

2006

;

25

(

47

):

6336

–

44

.

76.

Ween

MP

,

Oehler

MK

,

Ricciardelli

C

.

Role of versican, hyaluronan and CD44 in ovarian cancer metastasis

.

Int J Mol Sci

.

2011

;

12

(

2

):

1009

–

29

.

77.

Xing

D

,

Orsulic

S

.

A genetically defined mouse ovarian carcinoma model for the molecular characterization of pathway-targeted therapy and tumor resistance

.

Proc Natl Acad Sci U S A

.

2005

;

102

(

19

):

6936

–

41

.

78.

Xu

X

,

Ayub

B

,

Liu

Z

,

Serna

VA

,

Qiang

W

,

Liu

Y

, et al.

Anti-miR182 reduces ovarian cancer burden, invasion, and metastasis: an in vivo study in orthotopic xenografts of nude mice

.

Mol Cancer Ther

.

2014

;

13

(

7

):

1729

–

39

.

79.

Yousefi

M

,

Dehghani

S

,

Nosrati

R

,

Ghanei

M

,

Salmaninejad

A

,

Rajaie

S

, et al.

Current insights into the metastasis of epithelial ovarian cancer: hopes and hurdles

.

Cell Oncol

.

2020

;

43

(

4

):

515

–

38

.

80.

Zhang

J

,

Gold

KA

,

Lin

HY

,

Swisher

SG

,

Xing

Y

,

Lee

JJ

, et al.

Relationship between tumor size and survival in non-small-cell lung cancer (NSCLC): an analysis of the surveillance, epidemiology, and end results (SEER) registry

.

J Thorac Oncol

.

2015

;

10

(

4

):

682

–

90

.